Global Autoimmune Disease Diagnostics Market (By Disease, Test Types, Region), Key Company Profiles, Strategy, Financial Insights, Recent Developments - Forecast to 2030

Global Autoimmune Disease Diagnostics Market (By Disease, Test Types, Region), Key Company Profiles, Strategy, Financial Insights, Recent Developments - Forecast to 2030

The global autoimmune disease diagnostics market is predicted to reach US$ 10.5 Billion by 2030. Autoimmune diseases refer to a body’s abnormal immune response leading to production of antibodies that attack own cells and tissues, causing deterioration and destruction of healthy tissues. Autoimmune diseases can be divided into two general groups: Organ specific, where the autoantibodies attack a specific organ, and Non-organ specific (or systemic), where the autoantibodies attack multiple organ systems. There are almost 80 types of autoimmune diseases prevailing worldwide of which multiple sclerosis, type 1 diabetes, and rheumatoid arthritis are most common. As per the American Autoimmune Related Diseases Association, around 50 million Americans currently suffer from autoimmune related disorders. Moreover, the numbers are expected to escalate over the forecast period.

The tests used to diagnose the autoimmune disease include auto antibody test, antinuclear antibody test, complete blood count, C-reactive protein, and erythrocyte sedimentation rate. Rising prevalence of diseases such as rheumatoid arthritis, Hashimoto’s thyroiditis, and presence of favorable government regulations will render significant impact on the autoimmune disease diagnostics market growth.

Recent Developments

In June 2023, AstraZeneca signed an agreement with Quell Therapeutics potentially worth more than US$ 2 billion to develop cell therapies that could cure autoimmune diseases.
In August 2022, KSL Beutner Laboratories (Beutner) launched a blood test to detect an antigen linked with the autoimmune blistering disease mucous membrane pemphigoid (MMP), which often causes painful lesions in the oral cavity.
In June 2022, Theradiag announced an agreement with Quotient Limited under which the two companies will partner to advance autoimmune diagnostics by leveraging Quotient's MosaiQ platform.
In May 2022, Thermo Fisher Scientific announced the availability of the Phadia 2500+ Instrument in the U.S. for autoimmune testing.

By Disease Global Autoimmune Disease Diagnostics Market - Key Takeaway

On the basis of disease, Localized autoimmune disease segment accounted for largest market share in 2022 and is likely to dominate the market over the forecast timeframe.
Multiple sclerosis held highest share of the global localized autoimmune disease diagnostics market, followed by Inflammatory bowel disease segment.
Systemic autoimmune disease diagnostics segment will witness robust growth over the forecast timeframe.
Rheumatoid Arthritis accounted for approx. 50% share of the global systemic autoimmune disease diagnostics market in 2022, followed by Systemic lupus erythematosus (SLE).

By Tests Type Global Autoimmune Disease Diagnostics Market - Key Takeaway

Based on test types, Autoantibody test captured highest share of the overall autoimmune disease diagnostics market in 2022, followed by the antinuclear antibodies (ANA) test.
The complete blood count (CBC) is one of the most commonly ordered blood tests.
Erythrocyte Sedimentation Rate Tests captured around 6% - 8% share of the global autoimmune disease diagnostics market in 2022 followed by C -reactive protein test.
Urinalysis Tests and Comprehensive Metabolic Panel Tests are competing closely with each other to grab maximum share of the pie.

By Region Autoimmune Disease Diagnostics Market - Key Takeaway

North America dominates the global autoimmune disease diagnostics market and is likely to maintain its dominance over the forecast period.
Europe is the second largest region for autoimmune disease diagnostics market.
It is estimated that the prevalence rate of multiple sclerosis in Europe is 83 out of 100,000.
Asia-Pacific autoimmune disease diagnostics market is expected to grow at the fastest pace over the forecast period.
The Middle East & Africa and Latin America autoimmune disease diagnostics market is driven by the rising prevalence of autoimmune diseases and growing demand for better and accurate diagnostic procedures.

iGATE RESEARCH report titled “Global Autoimmune Disease Diagnostics Market (By Disease, Test Types, Region), Key Company Profiles, Strategy, Financial Insights, Recent Developments - Forecast to 2030” provides a comprehensive analysis of the Global Autoimmune Disease Diagnostic Market.

This 172 Page report with 68 Figures and 8 Tables has been analyzed from 8 View Points:

1) Global Autoimmune Disease Diagnostics Market and Forecast (2015 - 2030)
2) Global Autoimmune Disease Diagnostics Market Share and Forecast (2015 - 2030)
3) By Disease - Global Autoimmune Disease Diagnostics Market and Forecast (2015 - 2030)
4) By Test Type - Global Autoimmune Disease Diagnostics Market and Forecast (2015 - 2030)
5) By Region - Autoimmune Disease Diagnostics Market and Forecast (2015 - 2030)
6) Autoimmune Disease Diagnostics Market - Company Profiles
7) Global Autoimmune Disease Diagnostics Market - Recent Developments
8) Global Autoimmune Disease Diagnostics Market - Growth Drivers & Challenges

By Disease - Global Autoimmune Disease Diagnostics Market and Forecast

Systemic Autoimmune Disease Diagnostics Market

Rheumatoid Arthritis
Ankylosing Spondylitis
Systemic Lupus Erythematosus
Others Systemic Autoimmune Disease

Localized Autoimmune Disease Diagnostics Market

Inflammatory Bowel Disease
Multiple Sclerosis
Type 1 Diabetes
Hashimoto's Thyroiditis
Others Localized Autoimmune Disease

By Test Type - Global Autoimmune Disease Diagnostics Market and Forecast

Autoantibody Tests
Antinuclear Antibody (ANA) Tests
Complete Blood Count Tests
Erythrocyte Sedimentation Rate Tests
C- Reactive Protein (CRP) Tests
Urinalysis Tests
Comprehensive Metabolic Panel Tests
Others Tests

By Region - Autoimmune Disease Diagnostics Market and Forecast

1. North America
2. Europe
3. Asia Pacific
4. Latin America
5. Middle East & Africa

Autoimmune Disease Diagnostics Market - Key Company Profiles, Strategy, Recent Developments, Financial Insights

1. Abbott Laboratories
2. Siemens Healthineers
3. Roche Diagnostics
4. bioMerieux SA
5. EUROIMMUN AG
6. Bio-Rad Laboratories
7. Quest Diagnostics
8. Thermo Fischer Scientific Inc.

Data Source

iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

Primary Research Methodologies:

Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies:

Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.